All lobbying filings

ARENTFOX SCHIFF LLP

Lobbying for TRANSPARENCY-RX CORP. · Coalition of licensed transparent pharmacy benefit managers

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $20,000.00 income · posted Jul 13, 2026

Official filing document

Bills named in this filing 5

HR 7148
Consolidated Appropriations Act, 2026
HR 6609
Pharmacists Fight Back in Medicare and Medicaid Act
HR 6610
Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act]
HR 5582
Patients Deserve Price Tags Act
S 2355
Patients Deserve Price Tags Act

Lobbying activity 1

Health Issues

Pharmacy Benefit Manager reform Transparency in prescription drug markets Prescription drug prices H.R.7148 (Consolidated Appropriations Act, 2026), regarding Pharmacy Benefit Manager reform, transparency in prescription drug markets, and prescription drug prices H.R. 6609 and H.R. 6610 (Pharmacists Fight Back Act), generally H.R. 5582 and S. 2355 (Patients Deserve Price Tags Act), generally

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.